Madrigal Pharmaceuticals, Inc. (MDGL) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Madrigal Pharmaceuticals, Inc. (MDGL).

Download StockRank on Google Play Download StockRank on the App Store

Equity Overview

Price & Market Data

Price: $295.6

Daily Change: -$1.64 / 0.55%

Range: $289.0 - $297.8

Market Cap: $6,562,629,632

Volume: 268,790

Performance Metrics

1 Week: 6.23%

1 Month: 4.49%

3 Months: -15.15%

6 Months: -5.50%

1 Year: 1.23%

YTD: -4.21%

Company Details

Employees: 528

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.

Selected stocks

Pacific Gas & Electric Co. (PCG)

Public Service Enterprise Group Incorporated (PEG)

Pinnacle West Capital Corporation (PNW)